These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 19361304)
1. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Evison J; Farese S; Seitz M; Uehlinger DE; Furrer H; Mühlemann K Clin Infect Dis; 2009 May; 48(10):1402-12. PubMed ID: 19361304 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience with inactivated, virosomal influenza vaccine. de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120 [TBL] [Abstract][Full Text] [Related]
3. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
4. Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly. Ruf BR; Colberg K; Frick M; Preusche A Infection; 2004 Aug; 32(4):191-8. PubMed ID: 15293073 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
7. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. de Bruijn I; Meyer I; Gerez L; Nauta J; Giezeman K; Palache B Vaccine; 2007 Dec; 26(1):119-27. PubMed ID: 18063446 [TBL] [Abstract][Full Text] [Related]
8. The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects. de Bruijn IA; Nauta J; Gerez L; Palache AM Vaccine; 2006 Nov; 24(44-46):6629-31. PubMed ID: 16901593 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study. Salleras L; Domínguez A; Pumarola T; Prat A; Marcos MA; Garrido P; Artigas R; Bau A; Brotons J; Bruna X; Català P; Carreras E; Cuadra D; Gatell A; Millet S; Oller J; Raga E Vaccine; 2006 Nov; 24(44-46):6638-42. PubMed ID: 16842892 [TBL] [Abstract][Full Text] [Related]
10. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730 [TBL] [Abstract][Full Text] [Related]
11. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R; Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Souza AR; Braga JA; de Paiva TM; Loggetto SR; Azevedo RS; Weckx LY Vaccine; 2010 Jan; 28(4):1117-20. PubMed ID: 20116631 [TBL] [Abstract][Full Text] [Related]
13. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers. de Bruijn IA; Nauta J; Gerez L; Palache AM Virus Res; 2004 Jul; 103(1-2):139-45. PubMed ID: 15163502 [TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy. Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542 [TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months. Esposito S; Marchisio P; Ansaldi F; Bianchini S; Pacei M; Baggi E; Trabattoni D; Icardi G; Principi N Vaccine; 2010 Aug; 28(38):6137-44. PubMed ID: 20670909 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Marchisio P; Cavagna R; Maspes B; Gironi S; Esposito S; Lambertini L; Massimini A; Herzog C; Principi N Clin Infect Dis; 2002 Jul; 35(2):168-74. PubMed ID: 12087523 [TBL] [Abstract][Full Text] [Related]
18. The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study. Esposito S; Marchisio P; Montinaro V; Bianchini S; Weverling GJ; Pariani E; Amendola A; Fabiano V; Pivetti V; Zanetti A; Zuccotti GV Vaccine; 2012 Nov; 30(49):7005-12. PubMed ID: 23059357 [TBL] [Abstract][Full Text] [Related]
19. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants. Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980 [TBL] [Abstract][Full Text] [Related]
20. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]